Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Acumen Pharmaceuticals (ABOS) vs. Competitors

718 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
ABOSAcumen Pharmaceuticals$0.19$14.06M-0.13-88.31%HoldUnlock the ABOS analyst price target with TipRanks PremiumABOSUnlock the ABOS top-analyst price target with TipRanks Premium
VTGNVistaGen Therapeutics$0.20$9.21M-0.14-95.70%HoldUnlock the VTGN analyst price target with TipRanks PremiumABOS vs VTGNUnlock the VTGN top-analyst price target with TipRanks Premium
IKTInhibikase Therapeutics$1.38$193.57M-3.10-13.75%Strong BuyUnlock the IKT analyst price target with TipRanks PremiumABOS vs IKTUnlock the IKT top-analyst price target with TipRanks Premium
SRZNSurrozen$31.74$605.02M-0.72145.10%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumABOS vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
TCRXTScan Therapeutics$0.15$10.06M-0.17-85.05%HoldUnlock the TCRX analyst price target with TipRanks PremiumABOS vs TCRXUnlock the TCRX top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
ABOSAcumen Pharmaceuticals0.19-1.36-87.48%
VTGNVistaGen Therapeutics0.20-4.30-95.58%
IKTInhibikase Therapeutics1.38-0.18-11.54%
SRZNSurrozen31.7418.24135.11%
TCRXTScan Therapeutics0.15-0.88-85.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts